| Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open … HS Rugo, F Lerebours, E Ciruelos, P Drullinsky, M Ruiz-Borrego, ... The Lancet Oncology 22 (4), 489-498, 2021 | 220 | 2021 |
| Economic evaluations of clinical pharmacy services: 2006–2010 DR Touchette, F Doloresco, KJ Suda, A Perez, S Turner, Y Jalundhwala, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (8 …, 2014 | 175 | 2014 |
| Cost-effectiveness analysis of sacubitril/valsartan vs enalapril in patients with heart failure and reduced ejection fraction TA Gaziano, GC Fonarow, B Claggett, WW Chan, C Deschaseaux-Voinet, ... JAMA cardiology 1 (6), 666-672, 2016 | 168 | 2016 |
| Early adoption of sacubitril/valsartan for patients with heart failure with reduced ejection fraction: insights from Get With the Guidelines–Heart Failure (GWTG-HF) N Luo, GC Fonarow, SJ Lippmann, X Mi, PA Heidenreich, CW Yancy, ... JACC: Heart Failure 5 (4), 305-309, 2017 | 124 | 2017 |
| Home-time after discharge among patients hospitalized with heart failure SJ Greene, EC O’Brien, RJ Mentz, N Luo, NC Hardy, WK Laskey, ... Journal of the American College of Cardiology 71 (23), 2643-2652, 2018 | 83 | 2018 |
| Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey J Vietri, SJ Turner, H Tian, G Isherwood, MM Balp, S Gabriel Annals of Allergy, Asthma & Immunology 115 (4), 306-311, 2015 | 82 | 2015 |
| Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry AD DeVore, L Thomas, NM Albert, J Butler, AF Hernandez, JH Patterson, ... American Heart Journal 189, 177-183, 2017 | 63 | 2017 |
| A multicenter observational study of US adults with acute asthma: who are the frequent users of the emergency department? K Hasegawa, AF Sullivan, ET Hirashima, TJ Gaeta, C Fee, SJ Turner, ... The Journal of Allergy and Clinical Immunology: In Practice 2 (6), 733-740. e3, 2014 | 46 | 2014 |
| Treatment initiation patterns, modifications, and medication adherence among newly diagnosed heart failure patients: a retrospective claims database analysis C Deschaseaux, M McSharry, E Hudson, R Agrawal, SJ Turner Journal of Managed Care & Specialty Pharmacy 22 (5), 561-571, 2016 | 43 | 2016 |
| Comparison of US emergency department acute asthma care quality: 1997-2001 and 2011-2012 K Hasegawa, AF Sullivan, Y Tsugawa, SJ Turner, S Massaro, S Clark, ... Journal of Allergy and Clinical Immunology 135 (1), 73-80. e7, 2015 | 37 | 2015 |
| Effectiveness of Alpelisib + Fulvestrant Compared with Real-World Standard Treatment Among Patients with HR+, HER2–, PIK3CA-Mutated Breast Cancer S Turner, S Chia, H Kanakamedala, WC Hsu, J Park, D Chandiwana, ... The oncologist 26 (7), e1133-e1142, 2021 | 27 | 2021 |
| Health care costs for patients with heart failure escalate nearly 3-fold in final months of life EN Obi, JP Swindle, SJ Turner, PA Russo, A Altan Journal of managed care & specialty pharmacy 22 (12), 1446-1456, 2016 | 23 | 2016 |
| Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureus RL Soon, SJ Turner, A Forrest, BT Tsuji, J Brown International journal of antimicrobial agents 42 (1), 53-58, 2013 | 22 | 2013 |
| Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registry LA Allen, F Tang, P Jones, T Breeding, A Ponirakis, SJ Turner BMC Cardiovascular Disorders 18, 1-11, 2018 | 16 | 2018 |
| Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients SJ Turner, SCA Chen, MA Slavin, DCM Kong Expert review of pharmacoeconomics & outcomes research 13 (2), 227-235, 2013 | 13 | 2013 |
| Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia J Lin, Y Li, H Tian, MJ Goodman, S Gabriel, T Nazareth, SJ Turner, ... ClinicoEconomics and Outcomes Research, 349-356, 2014 | 12 | 2014 |
| Pharmacoeconomic evaluation of caspofungin versus liposomal amphotericin B in empirical treatment of invasive fungal infections in Turkey SJ Turner, E Senol, A Kara, D Al-Badriyeh, DCM Kong, EC Dinleyici International journal of antimicrobial agents 42 (3), 276-280, 2013 | 12 | 2013 |
| Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST) EF Lewis, TM Coles, S Lewis, LM Nelson, A Barrett, CDM Romano, ... Journal of patient-reported outcomes 3, 1-15, 2019 | 11 | 2019 |
| Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey SJ Turner, E Senol, A Kara, D Al-Badriyeh, EC Dinleyici, DCM Kong BMC Infectious Diseases 13, 1-9, 2013 | 11 | 2013 |
| Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre C Twelves, S Cheeseman, W Sopwith, M Thompson, M Riaz, ... BMC cancer 20, 1-12, 2020 | 10 | 2020 |
